Revenues in FY16 reached US$12,790m (-5% and -2% at CER), EBITDA US$2,659m (-4%m, +2% at CER), operating income US$1,647m (-11%) and net income US$1,178m (-12%). Net debt at the end of FY16 was US$2.3bn (US$3.09bn in FY15). No regular dividend will be proposed at the AGM in June (with a CHF5 dividend to be paid conditional upon and prior to the first settlement of the transaction. The expected closing of the deal with ChemChina is in Q2. For FY17, management expects a low single-digit sales g ....